Paradoxical exacerbation of psoriasis in AIDS: Proposed explanations including the potential roles of substance P and gram-negative bacteria

Autoimmunity

Volumn 37, Issue 1, 2004, Pages 67-71

  Namazi, M R ^a  

^a SHIRAZ UNIVERSITY   (Iran)

Author keywords

AIDS; Cytokines; HIV; Infection; Lipopolysaccharide; Psoriasis

Indexed keywords

CALCIPOTRIOL; CAPSAICIN; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; DITHRANOL; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL COLONIZATION; CONCENTRATION (PARAMETERS); DISEASE COURSE; DISEASE EXACERBATION; DRUG INHIBITION; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; KERATINOCYTE; LANGERHANS CELL; MACROPHAGE; NERVE CELL; NONHUMAN; PATHOGENESIS; PROGNOSIS; PROTEIN SECRETION; PSORIASIS; REVIEW; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ULTRAVIOLET IRRADIATION; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; COMMUNICABLE DISEASES; GRAM-NEGATIVE BACTERIA; HUMANS; PSORIASIS; SKIN DISEASES, BACTERIAL; SUBSTANCE P;

EID: 0442326215     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930310001637986     Document Type: Review

References (62)

1. Camp, R.D.R. (1998) "Psoriasis", In: Champion, R.H., Burton, J.L. and Ebling, F.J.G., eds, Rook/ Wilkinson/ Ebling. Textbook of Dermatology, 6th Ed. (Blackwell Scientific Publications, Oxford) Vol. 4, pp 1589-1649.
2. Lazar, A.P. and Roenigk, H.H. (1988) "Acquired immunodeficiency syndrome (AIDS) can exacerbate psoriasis", J. Am. Acad. Dermatol. 18, 144.
3. Duvic, M., Johnson, T.M. and Rapini, R.P. (1987) "Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome", Arch. Dermatol. 123, 1622-1632.
4. Colebunders, R., Blot, K., Meriens, V. and Dock, P. (1992) "Psoriasis regression in terminal AIDS (letter)", Lancet 339, 1110.
5. Lisi, P. (1973) "Investigation on Langerhans cells in pathological human epidermis", Acta Dermatol. Venereol. (Stockh) 53, 425-428.
6. Haftek, M., Faure, M., Schmitt, D. and Thivolet, J. (1982) "Effects of aromatic retinoid treatment on epidermal Largerhans cells in psoriasis: A quantitative study", J. Invest. Dermatol. 78, 327, (Abstr).
7. Harper, J.I. and Zemelman, V. (1988) "Cyclosporin for psoriasis: Changes in T-cell subsets and Langerhans cells in lesional and non-lesional skin (during a six month treatment period)", In: Van Joost, T.H., Heule F. and Bos, J.D., eds, Cyclosporin in Psoriasis (Sandoz Publications), p 109.
8. Zemelman, V., Neer, F.V., Roberts, N., Patel, P., Jangtry, J. and Staughton, R.C.D. (1994) "Epidermal Langerhans cells, HIV-1 infection and psoriasis", Br. J. Dermatol. 130, 307-311.
9. Belsito, D.V., Sanches, M.R., Baer, R., Valentine, F. and Thorbeche, G.J. (1984) "Reduced Langerhans cell antigen and ATPase activity in patients with the acquired immunodeficiency syndrome", N. Engl. J. Med. 310, 1279-1282.
10. Ortonne, J.P. (1999) "Recent developments in the understanding of the pathogenesis of psoriasis", Br. J. Dermatol. 140(Suppl. 54), 1-7.
11. Parish, W.E. and Breathnach, S.M. (1998) "Clinical immunology and allergy", In: Champion, R.H., Burton, J.L. and Ebling, F.J.G., eds, Rook/ Wilkinson/ Ebling. Textbook of Dermatology, 6th Ed. (Blackwell Scientific Publications, Oxford) Vol. 4, p 292.
12. Placek, W., Haftek, M. and Thivolet, J. (1988) "Sequence of changes in psoriatic epidermis", Acta Derm. Venereol (Stockh) 68, 369-372.
13. Ramirez-Bosca, M., Martinez-Ojeda, L., Valcuende-Cavero, F., et al. (1989) "A study of local immunity in psoriasis", Br. J. Dermatol. 119, 587-595.
14. Mallon, E., Young, D., Bunce, M., Gotch, F.M., Easterbook, P.J., Newson, R. and Bunker, C.B. (1998) "HLA-Cw*0602 and HIV-associated psoriasis", Br. J. Dermatol. 139, 527-533.
15. Duvic, M. (1990) "Immunology of AIDS related to psoriasis", J. Invest. Dermatol. 95, 385-405.
16. Leung, D.Y.M., Walsh, P., Giorn, R. and Noris, D.A. (1993) "A potential role for superantigens in the pathogenesis of psoriasis", J. Invest. Dermatol. 100, 225-228.
17. Valdimarsson, H., Baker, B.S., Jonsdottir, I., et al. (1995) "Psoriasis: A T-cell mediated autoimmune disease induced by streptococcal syperantigens?", Immunol. Today 16, 145-149.
18. Gottlieb, A.B., Lifshitz, B., Fu, S.M., et al. (1986) "Expression of HLA-DR molecule by keratinocytes and presence of Langerhans' cells in the dermal infiltrate of active psoriatic plaques", J. Exp. Med. 164, 1013-1028.
19. Tokura, Y., Yagi, J., O'Malley, M., et al. (1994) "Superantigenic staphylococcal exotoxins induce T cell proliferation in presence of Langerhans cells or class II-bearing keratinocytes to produce T-cell-activating cytokines", J. Invest. Dermatol. 102, 31-38.
20. Aukrust, P., Liabakk, N., Muller, F., et al. (1994) "Serum levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection-correlations to clinical, immunological, and virologic parameters", J. Infect. Dis. 169, 420-424.
21. Craven, D.E. (1995) "Staphylococcus aureus colonisation and bacteremia in persons infected with human immunodeficiency virus: A dynamic interaction with the host", J. Chemother. 7(Suppl. 3), 19-28.
22. Leonard, J.M., Abramczuk, J.W., Pezen, D.S., Rutledge, R., Belcher, J.H., Hakim, F., et al. (1988) "Development of disease and virus recovery in transgenic mice containing HIV proviral DNA", Science 242, 1665-1670.
23. Duvic, M., Crane, M.M., Conant, M., Mahoney, S.E., Reveille, J.D. and Lehrman, S.N. (1994) "Zidovudine improves psoriasis in human immunodeficiency virus-positive males", Arch. Dermatol. 130, 447.
24. Bonnekon, B., Wevers, A., Geisel, J., Rasokat, H. and Mahrle, G. (1991) "Antiproliferative potential of zidovudine in human keratinocyte cultures", J. Am. Acad. Dermatol. 25, 483-490.
25. Camisa, C. (1998) "Conditions associated with psoriasis", In: Camisa, C., ed, Handbook of Psoriasis, 1st Ed. (Blackwell Scientific Publications, Oxford), p 69.
26. Kedzierska, K. and Crowe, S.M. (2001) "Cytokines and HIV-1: Interactions and clinical implications", Antivir. Chem. Chemother. 12(3), 133-150.
27. Emilie, D., Fior, R., Jarrousse, B., Marfaing-Koka, A., Merrien, D., Deverrie, N., Devergne, O., et al. (1994) "Cytokines in HIV infection", Int. J. Immunopharmacol. 16(5-6), 391-396.
28. Ormerod, A.D., Weller, R., Copeland, P., et al. (1998) "Detection of nitric oxide and nitric synthases in psoriasis", Arch. Dermatol. Res. 290, 3-8.
29. Orem, A., Aliyazicioglu, R., Kiran, E., Vanizor, B., Cimnodeirt, G. and Deger, O. (1997) "The relationship between nitric oxide production and activity of the disease in patients with psoriasis", Arch. Dermatol. 133, 1606-1607.
30. Morhen, V.B. (1997) "Langerhans cells may trigger the psoriatic disease process via production of nitric oxide", Immunol. Today 18(9), 433-436.
31. Pietraforte, D., Tritarelli, E., Testa, U. and Minetti, M. (1994) "gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages", J. Leukoc. Biol. 55(2), 175-182.
32. Evans, T.G., Rasmussen, K., Wiebke, G. and Hibbs, J.B. Jr. (1994) "Nitric oxide synthesis in patients with advanced HIV infection", Clin. Exp. Immunol. 97(1), 83-86.
33. Weller, R. (1999) "Nitric oxide, skin growth and differentiation: More questions than answers?", Clin. Exp. Dermatol. 24, 388-391.
34. Namazi, M.R. (2003) "A complementary note on the Morhenn's hypothesis on the pathomechanism of psoriasis", Immunol. Lett. 85(3), 223.
35. Jiang, W.Y., Raychaudhari, S.P. and Farber, E.M. (1988) "Double-labeled immunoflourescence study of cutaneous nerves in psoriasis", Int. J. Dermatol. 37, 572-574.
36. NauRarinen, A., Nickoloff, B.J. and Farber, E.M. (1989) "Quantification of cutaneous sensory nerves and their substance P content in psoriasis", J. Invest. Dermatol. 92, 126-129.
37. Al'abadie, M.S.K., Senior, H.J., Bleehen, S.S., et al. (1992) "Neurogenic changes in psoriasis: An immunohistochemical study", J. Invest. Dermatol. 98, 535.
38. Naukkavinen, A., Harvima, I., Paukkonen, K., et al. (1996) "Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions", Arch. Dermatol. Res. 285, 341-346.
39. Farber, E.M., Nickoloff, B.J., Redrt, B. and Fraki, J.E. (1986) "Stress, symmetry, and psoriasis: Possible role of neuropeptides", J. Am. Acad. Dermatol. 14, 305-311.
40. Park, Y.M. and Kim, C.W. (1999) "The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human kertinocytes", J. Dermatol. Sci. 22(1), 17-23.
41. Matis, W.L., Lavker, R.M. and Murphy, G.F. (1990) "Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium", J. Invest. Dermatol. 94, 492-495.
42. Ansel, J.C., Armstrong, C.A., Song, I., Quinlan, K.L., Olerud, J.E., Caughman, S.W., et al. (1997) "Interactions of the skin and nervous system", J. Invest. Dermatol. Symp. Proc. 2(1), 23-26.
43. Eeday, D.J., Johnson, C.F., Shaw, C. and Buchanan, K.D. (1991) "Neuropeptides in psoriasis: An immunocytochemical and radioimmunoassay study", J. Invest. Dermatol. 96(4), 434-438.
44. Nilsson, J., Von Euler, A.M. and Dalsgaard, C.-J. (1985) "Stimulation of connective tissue cell growth by substance P and substance K", Nature 315-61-315-63.
45. Panconesi, E. and Hautmann, G. (1996) "Pathophysiology of stress in dermatology: The psychobiologic pattern of psychosomatics", Dermatol. Clin. 14, 399-421.
46. Farber, E.M., Rein, G. and Lanigan, S.W. (1991) "Stress in psoriasis: Psychoneuroimmunologic mechanisms", Int. J. Dermatol. 30, 8-12.
47. Smith, C.H., Barker, J.N.W.N., Morris, R.W., et al. (1993) "Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin", J. Immunol. 151, 3274-3282.
48. Ellis, C.N., Berberian, B., Sulica, V.I., Dodd, W.A., Jarratt, M.T., Katz, H.I., et al. (1993) "A double-blind evaluation of topical capsaicin in pruritic psoriasis", J. Am. Acad. Dermatol. 29, 438-442.
49. Cotterill, J.A. and Millard, L.G. (1998) "Psychosomatic disorders", In: Champion, R.H., Burton, J.L. and Ebling, F.J.G., eds, Rook/Wilkinson/Ebling Textbook of Dermatology, 6th Ed. (Blackwell Scientific Publications, Oxford) Vol. 2, p 2787.
50. O'Dorisio, M.S. (1988) "Neuropeptide modulation of the immune response in gut associated lymphoid tissue", Int. J. Neurosci. 38, 189-198.
51. Rugg, M.R., Wahl, S.M. and Pert, C.B. (1985) "Substance P receptor-mediated chemotaxis of human monocytes", Peptides 6(Suppl. 2), 107-111.
52. Lotz, M., Vaughon, J.H. and Garson, D.A. (1988) "Effect of neuropeptides on production of inflammatory cytokines by human monocytes", Science 241, 1218-1221.
53. Bernow, B. (1983) "Substance P", Pharmacol. Rev. 35, 85-141.
54. Forman, J.C. (1987) "Substance P and calcitonin-gene-related peptide: Effects on mast cells and in human skin", Int. Arch Allergy Appl. Immunol. 82, 366-371.
55. Benrath, J., Eschenfelder, C., Zimmeremann, M. and Giillardon, F. (1995) "Calcitonin gene-related peptide, substance P and nitric oxide are involved in cutaneous inflammation following ultra-violet irradiation", Eur. J. Pharmacol. 293, 87-96.
56. Camisa, C. (1998) "Pathogenesis of psoriasis", In: Camisa, C., ed, Handbook of Psoriasis, 1st Ed. (Blackwell Scientific Publications, Oxford), pp 47-49.
57. Douglas, S.D., Ho, W.Z., Getted, D.R., Cnaan, A., Zhao, H., Leserman, J., et al. (2001) "Elevated substance P levels in HIV-infected men", AIDS 15(15), 2043-2045 (Abstr.).
58. Ho, W.Z., Lai, J.P., Li, Y. and Doglas, S.D. (2002) "HIV enhances substance P expression in human immune cells", FASEB J. 16(6), 616-618 (Abstr.).
59. Stingel, G., Rappersberge, K., Tschachler, E., Gartner, S., Groh, V., Mann, D.L., et al. (1990) "Langerhans" cells in HIV-1 infection", J. Am. Acad. Dermatol. 22, 1210-1217.
60. O'Neill, T.P. (1991) "Mechanism of capsaicin action: Recent learnings", Respir. Med. (Suppl. A), 35-41.
61. Li, Y., Douglas, S.D., Song, L., Sun, S. and Ho, W.Z. (2001) "Substance P enhances HIV-1 replication in human immune cells", J. Neuroimmunol. 121(1-2), 67-75.
62. Karhukrpi, J., Ikaheimo, I., Karvonen, J. and Karttunen, R. (2002) "Promoter region polymorphism of the CD14 gene (C-159T) is not associated with psoriasis vulgaris", Eur. J. Immunogenet. 29, 57-60.